VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OPRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OPRXOptimizeRx Corporation
$5.43$102M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOPRXQuarterly Financials

OptimizeRx Corporation (OPRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

OptimizeRx Corporation (OPRX) quarterly income statement — complete revenue, gross profit & net income history

OPRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue19.84M32.24M26.07M29.2M21.93M32.32M21.31M18.81M19.69M28.37M16.33M13.82M13M19.65M15.09M13.98M13.73M20.31M16.12M13.63M
Revenue Growth %-9.5%-0.24%22.33%55.19%11.37%13.91%30.48%36.14%51.43%44.34%8.26%-1.15%-5.31%-3.24%-6.45%2.59%22.28%23.66%53.29%55.13%
Cost of Goods Sold5.98M8.14M8.55M10.56M8.58M10.29M7.86M7.11M7.49M10.53M6.53M5.99M5.57M7.2M5.66M4.99M5.63M7.92M7.05M5.58M
COGS % of Revenue30.11%25.25%32.8%36.17%39.15%31.85%36.9%37.78%38.02%37.11%39.99%43.37%42.84%36.63%37.55%35.69%41%39%43.71%40.96%
Gross Profit13.87M24.1M17.52M18.64M13.34M22.02M13.45M11.7M12.2M17.84M9.8M7.83M7.43M12.45M9.42M8.99M8.1M12.39M9.08M8.04M
Gross Margin %69.89%74.75%67.2%63.83%60.85%68.15%63.1%62.22%61.98%62.89%60.01%56.63%57.16%63.37%62.45%64.31%59%61%56.29%59.04%
Gross Profit Growth %3.93%9.43%30.26%59.22%9.34%23.44%37.21%49.57%64.19%43.25%4.03%-12.96%-8.25%0.51%3.79%11.75%32.28%44.02%50.92%56.38%
Operating Expenses13.47M15.16M15.47M15.45M15.46M18.39M22.01M15.45M17.23M28.74M13.35M12.67M14.5M13.32M13.18M12.9M11.86M11.77M9.04M7.7M
OpEx % of Revenue67.89%47.03%59.33%52.91%70.49%56.9%103.29%82.14%87.52%101.32%81.76%91.72%111.48%67.76%87.35%92.27%86.39%57.95%56.06%56.54%
Selling, General & Admin8.24M14.09M14.39M14.37M14.36M17.3M13.43M14.38M16.17M18.86M12.89M12.21M14.03M14.26M12.66M12.32M11.39M9.68M8.08M6.93M
SG&A % of Revenue41.53%43.69%55.19%49.23%65.51%53.52%63%76.44%82.1%66.48%78.91%88.36%107.91%72.54%83.93%88.14%82.96%47.68%50.12%50.87%
Research & Development3.4M080K091K091K71K71K048K000000000
R&D % of Revenue17.14%-0.31%-0.41%-0.43%0.38%0.36%-0.29%---------
Other Operating Expenses1000K1000K1000K1000K1000K1000K1000K1000K996K1000K419K465K464K-938.46K515.83K578.12K471.54K1000K957.3K772.56K
Operating Income396K8.94M2.05M3.19M-2.11M3.63M-8.56M-3.75M-5.03M-10.9M-3.55M-4.85M-7.06M-864.35K-3.76M-3.91M-3.76M621.08K38.19K340.14K
Operating Margin %2%27.72%7.86%10.92%-9.64%11.25%-40.18%-19.93%-25.54%-38.43%-21.76%-35.09%-54.32%-4.4%-24.9%-27.96%-27.39%3.06%0.24%2.5%
Operating Income Growth %118.73%145.93%123.94%185.06%57.96%133.33%-140.98%22.69%28.8%-1161.43%5.42%-24.06%-87.79%-239.17%-9937.02%-1249.1%-489.23%-54.21%121.61%132.22%
EBITDA1.46M10.02M2.99M4.26M-1.02M4.73M-7.47M-2.68M-3.96M-9.9M-3.15M-4.38M-6.6M-407.8K-3.52M-3.36M-3.32M1.1M564.23K897.96K
EBITDA Margin %7.36%31.06%11.47%14.6%-4.65%14.63%-35.04%-14.22%-20.12%-34.89%-19.27%-31.73%-50.75%-2.07%-23.33%-24%-24.16%5.4%3.5%6.59%
EBITDA Growth %243.14%111.82%140.06%259.3%74.26%147.77%-137.27%38.96%39.96%-2326.89%10.59%-30.67%-98.91%-137.18%-723.83%-473.63%-2858.75%-37.82%62.74%267.84%
D&A (Non-Cash Add-back)1.06M1.08M941K1.07M1.09M1.09M1.09M1.07M1.07M1.01M406K465K464K456.55K236.93K553.48K443.52K475.62K526.03K557.82K
EBIT396K8.71M2.2M3.32M-1.99M3.77M-8.42M-3.57M-5.01M-8.21M-3.55M-4.13M-6.4M-864.35K-3.76M-3.91M-3.76M621.08K38.19K340.14K
Net Interest Income-1.08M-1.16M-1.06M-1.51M-1.21M-1.47M-1.42M-1.42M-1.53M-1.34M688.19K721K665K538.51K289.97K23.82K32.38K1.7K11.96K
Interest Income77K84K91K90K88K98K107K106K20K117.61K688.19K721K665K538.51K289.97K23.82K32.38K1.7K11.96K
Interest Expense1.16M1.24M1.15M1.6M1.3M1.56M1.52M1.53M1.55M1.45M0000000000
Other Income/Expense-1.04M-1.47M-1M-1.48M-1.17M-1.43M-1.38M-1.35M-1.53M-836.15K688K721K665K538.51K289.97K23.82K32.38K1.7K11.96K
Pretax Income-644K7.47M1.05M1.71M-3.28M2.21M-9.94M-5.1M-6.55M-11.74M-2.87M-4.13M-6.4M-325.84K-3.47M-3.88M-3.76M623.46K39.89K352.1K
Pretax Margin %-3.25%23.17%4.02%5.87%-14.98%6.83%-46.65%-27.09%-33.29%-41.38%-17.54%-29.87%-49.2%-1.66%-22.98%-27.79%-27.39%3.07%0.25%2.58%
Income Tax-149K2.45M270K181K-1.08M2.29M-817K-1.09M344K-7.6M033K00000000
Effective Tax Rate %23.14%32.81%25.74%10.57%33.04%103.53%8.22%21.35%-5.25%64.72%0%-0.8%0%0%0%0%0%0%0%0%
Net Income-495K5.02M779K1.53M-2.2M-78K-9.12M-4.01M-6.9M-4.14M-2.87M-4.16M-6.4M-325.84K-3.47M-3.88M-3.76M623.46K39.89K352.1K
Net Margin %-2.49%15.57%2.99%5.25%-10.03%-0.24%-42.82%-21.31%-35.04%-14.6%-17.54%-30.11%-49.2%-1.66%-22.98%-27.79%-27.39%3.07%0.25%2.58%
Net Income Growth %77.49%6535.9%108.54%138.22%68.13%98.12%-218.46%3.68%-7.83%-1171.01%17.36%-7.11%-70.11%-152.26%-8790.01%-1203.3%-490.09%-54.06%114.1%132.68%
Net Income (Continuing)-495K5.02M779K1.53M-2.2M-78K-9.12M-4.01M-6.9M-4.14M-2.87M-4.16M-6.4M-325.84K-3.47M-3.88M-3.76M623.46K39.89K352.1K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.030.260.040.08-0.12-0.00-0.50-0.22-0.38-0.23-0.17-0.24-0.37-0.02-0.19-0.21-0.210.030.000.02
EPS Growth %78%-108%136.64%68.42%98.26%-194.12%8.33%-2.7%-1163.74%10.53%-14.29%-76.19%-153.06%--1150%-430.3%-57.13%111%127.21%
EPS (Basic)-0.030.270.040.08-0.12-0.00-0.50-0.22-0.38-0.23-0.17-0.24-0.37-0.02-0.19-0.21-0.210.040.000.02
Diluted Shares Outstanding18.76M19.38M19.02M19.02M18.47M18.42M18.32M18.26M18.17M17.65M16.64M16.99M17.09M17.88M17.98M18.12M17.88M18.2M18.2M18.1M
Basic Shares Outstanding18.76M18.66M18.52M18.51M18.47M18.42M18.32M18.26M18.17M17.65M16.64M16.99M17.09M17.88M17.98M18.12M17.88M17.64M17.64M17.35M
Dividend Payout Ratio--------------------